Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peakman, M.
Right arrow Articles by Roep, B. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peakman, M.
Right arrow Articles by Roep, B. O.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:1749-1754, 2001
© 2001 by the American Diabetes Association, Inc.

Characterization of Preparations of GAD65, Proinsulin, and the Islet Tyrosine Phosphatase IA-2 for Use in Detection of Autoreactive T-Cells in Type 1 Diabetes

Report of Phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell Assays in Type 1 Diabetes

Mark Peakman1, Timothy I. Tree1, Josef Endl2, Peter van Endert3, Mark A. Atkinson4, and Bart O. Roep5

1 Department of Immunology, Guy’s King’s and St. Thomas’ School of Medicine, London, United Kingdom
2 Roche Diagnostics, Penzberg, Germany
3 Institut National de la Santé et de la Recherche Médicale Unité 25, Paris, France
4 Department of Pathology, University of Florida, Gainesville, Florida
5 Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands

The identification, quantification, and characterization of T-cells reactive with the islet autoantigens GAD65, proinsulin (PI), and tyrosine phosphatase–like molecules IA-2 and phogrin are major research goals in type 1 diabetes. In the Immunology of Diabetes Society First Workshop on Autoreactive T-Cells, the quality of recombinant preparations of these autoantigens was identified as a significant weakness, a finding that may account for much of the inconsistency in published studies of peripheral blood T-cell reactivity to islet autoantigens. Poor antigen quality has also hampered the development of novel technologies for the detection of islet-reactive T-cells. For these reasons, in the present study, several preparations of GAD65, PI, and IA-2 were collected and evaluated for endotoxin content, ability to stimulate a panel of relevant T-cell clones, and inhibitory effects on proliferation to unrelated third-party antigens. Through this process, we have been able to identify preparations of GAD65 and IA-2, generated in insect cells using the baculovirus expression system, that stimulate relevant clones and display low inhibitory effects on third-party antigens. In addition, we characterized a PI preparation generated in bacteria as being free of effects on proliferation to third-party antigens and low in endotoxin content. These preparations are important to promote the development of robust and sensitive assays of islet-reactive T-cells in patients with type 1 diabetes or patients at high risk for developing the disease.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
A Mayer, N Fabien, M C Gutowski, V Dubois, L Gebuhrer, J Bienvenu, J Orgiazzi, and A M Madec
Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults
Eur. J. Endocrinol., July 1, 2007; 157(1): 53 - 61.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Tiittanen, J. T. Huupponen, M. Knip, and O. Vaarala
Insulin Treatment in Patients With Type 1 Diabetes Induces Upregulation of Regulatory T-Cell Markers in Peripheral Blood Mononuclear Cells Stimulated With Insulin In Vitro
Diabetes, December 1, 2006; 55(12): 3446 - 3454.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Jaeckel, H. von Boehmer, and M. P. Manns
Antigen-Specific FoxP3-Transduced T-Cells Can Control Established Type 1 Diabetes
Diabetes, February 1, 2005; 54(2): 306 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
I. S. Yap, G. Giddings, E. Pocock, and J. K. Chantler
Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4
J. Gen. Virol., November 1, 2003; 84(11): 3051 - 3068.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. E. Greening, T. I.M. Tree, K. T. Kotowicz, A. G. van Halteren, B. O. Roep, N. J. Klein, and M. Peakman
Processing and Presentation of the Islet Autoantigen GAD by Vascular Endothelial Cells Promotes Transmigration of Autoreactive T-Cells
Diabetes, March 1, 2003; 52(3): 717 - 725.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Kotani, M. Nagata, H. Moriyama, M. Nakayama, K. Yamada, S. A. Chowdhury, S. Chakrabarty, Z. Jin, H. Yasuda, and K. Yokono
Detection of GAD65-Reactive T-Cells in Type 1 Diabetes by Immunoglobulin-Free ELISPOT Assays
Diabetes Care, August 1, 2002; 25(8): 1390 - 1397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.